These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11782253)

  • 21. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
    Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI
    J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.
    Duesberg PH
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):755-64. PubMed ID: 2644642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2.
    Castro BA; Nepomuceno M; Lerche NW; Eichberg JW; Levy JA
    Virology; 1991 Sep; 184(1):219-26. PubMed ID: 1678564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV Interaction With Human Host: HIV-2 As a Model of a Less Virulent Infection.
    Azevedo-Pereira JM; Santos-Costa Q
    AIDS Rev; 2016; 18(1):44-53. PubMed ID: 26936760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.
    Santana VC; Almeida RR; Ribeiro SP; Ferreira LC; Kalil J; Rosa DS; Cunha-Neto E
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1010-6. PubMed ID: 26602876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen.
    Leung L; Srivastava IK; Kan E; Legg H; Sun Y; Greer C; Montefiori DC; zur Megede J; Barnett SW
    AIDS; 2004 Apr; 18(7):991-1001. PubMed ID: 15096801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
    Leligdowicz A; Rowland-Jones S
    Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced rate of disease development after HIV-2 infection as compared to HIV-1.
    Marlink R; Kanki P; Thior I; Travers K; Eisen G; Siby T; Traore I; Hsieh CC; Dia MC; Gueye EH
    Science; 1994 Sep; 265(5178):1587-90. PubMed ID: 7915856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an AIDS vaccine: a daunting epidemiological challenge.
    Nathanson N; Mathieson BJ
    Eur J Epidemiol; 2005; 20(2):123-6. PubMed ID: 15792276
    [No Abstract]   [Full Text] [Related]  

  • 33. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
    Horton H; Havenar-Daughton C; Lee D; Moore E; Cao J; McNevin J; Andrus T; Zhu H; Rubin A; Zhu T; Celum C; McElrath MJ
    J Virol; 2006 Oct; 80(19):9779-88. PubMed ID: 16973582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene.
    Casimiro DR; Tang A; Chen L; Fu TM; Evans RK; Davies ME; Freed DC; Hurni W; Aste-Amezaga JM; Guan L; Long R; Huang L; Harris V; Nawrocki DK; Mach H; Troutman RD; Isopi LA; Murthy KK; Rice K; Wilson KA; Volkin DB; Emini EA; Shiver JW
    J Virol; 2003 Jul; 77(13):7663-8. PubMed ID: 12805466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models for the study of human immunodeficiency virus infections.
    Letvin NL
    Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
    Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
    J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design.
    Howie S; Ramage R; Hewson T
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 2):S141-5. PubMed ID: 11029383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.